Skip to main content

Table 1 Forced Vital Capacity (FVC) in three times of evaluation according to the age (≤10 years and >10 years), age of onset of steroid therapy (≤7 years and >7 years), and walking capacity (ambulant and non-ambulant)

From: Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy

  

FVC (L/%)

  
 

Evaluation I

Evaluation II

Evaluation III

 

Age (≤10 years)

1.6 ± 0.3/

1.7 ± 0.4/

1.7 ± 0.4/

p1 = 0.24/0.59

n = 9

78.8 ± 12.5

80.1 ± 16.6

75.2 ± 20.2

p2 = 0.07/0.31

Age (>10 years)

1.7 ± 0.4/

1.8 ± 0.4/

1.7 ± 0.4/

p3 = 0.19/0.09

n = 12

66 ± 22.1

65.5 ± 24.7

60.5 ± 23.6

 

Age of onset of steroid therapy (≤7 years)

1.6 ± 0.3 / 75.9 ± 16.3

1.7 ± 0.5 / 78.5 ± 22.5

1.7 ± 0.4 / 74.7 ± 25.5

p1 = 0.24/0.61

    

p2 = 0.05/0.25

    

p3 = 0.21/0.23

n = 10

    

Age of onset of steroid

1.7 ± 0.4 / 66.9 ± 21.3

1.8 ± 0.4 / 66.1 ± 21.7

1.7 ± 0.3 / 59.6 ± 18.5

 

therapy (>7 years)

    

n = 11

    

Ambulant

1.7 ± 0.4 / 86.2 ± 10.6

1.9 ± 0.4 / 92.3 ± 11.5

1.9 ± 0.3 / 87.2 ± 15.6

p1 = 0.37/0.65

    

p2 = 0.41/0.99

n = 9

   

p3 = 0.83/0.67

Non-ambulant

1.6 ± 0.4 / 60 ± 16.3

1.6 ± 0.4 /56.7 ± 15.1

1.5 ± 0.3 / 51.5 ± 13.3

 

n = 12

    
  1. Table legend: p1 = comparison between the three evaluations, p2 = comparison between both groups, p3 = interaction effect.